Healthcare leaders, federal policy makers, academic leaders, consumer and patient advocacy groups, and others with an interest will hear from recognized experts in the area of personalized health care. Industry leaders will discuss leveraging scientific discoveries from genomics and DNA research to improve health care outcomes and effectiveness.
“We are in the midst of a transformation in medicine and this year’s conference explores many of those changes, along with the great potential for predictive, preventive, personalized and participatory health care,” says Dr. Clay Marsh, executive director of the OSU Center for Personalized Health Care. “At the same time, we are providing a timely forum to address many issues high on the agenda of the current policy reform debate,” adds Marsh, who also is senior associate vice president for research in the Office of Health Sciences, and vice dean for research in the College of Medicine.
With a conference theme of “Transforming Health Care Through Personalized Medicine,” participating speakers include Dr. Leroy Hood, president, Institute for Systems Biology; Dr. Ralph Snyderman, chancellor emeritus, Duke University Medical System; Dr. Daniel Levy, director, Framingham Heart Study, and professor of medicine, Boston University School of Medicine; and Lawrence Lesko, director, Office of Clinical Pharmocology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
Speakers and expert panels will discuss the role of academic medical centers in advancing personalized health care in both research and clinical practice; personalized medicine and participatory health care; population genetics and heart risk profiling; developing a medicine model to advance personalized health care; how the patient-centered medical home model can improve patient health and strengthen the healthcare delivery system; consumer genetics, ethics and genetic counseling; developing a personalized cancer care policy agenda and its implications for health care reform; personalized cancer care – targeted therapeutics for diagnosing and treating hematological malignancies; and pharmacogenomics in clinical medicine.
Personalized health care utilizes gene-based information to understand each person’s individual requirements for maintaining their health, preventing disease and tailoring therapies. It incorporates knowledge of an individual’s environment, health-related behaviors, culture and values.
Complete information about the conference program, including registration and keynote speakers, is available at http://www.ced.osu.edu/PersonalizedHealthCare/.
Contact: Doug Flowers, Medical Center Communications, (614) 293-3737, or Doug.Flowers@osumc.edu
Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June
24.05.2017 | Institute for Advanced Sustainability Studies e.V.
AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises
23.05.2017 | Fraunhofer-Institut für Produktionstechnologie IPT
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy